MARKETS / NYSE / DD

NYSE · PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS · LARGE CAP

DuPont de Nemours, Inc. DD

11 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$6.8B

▲ 1.9% YoY

Net income

$-779.0M

▼ 210.8% YoY

Free cash flow

$227.0M

▼ 52.7% YoY

In brief

What this company does

DuPont de Nemours, Inc. provides advanced solutions across healthcare, water, construction and industrial markets. At December 31, 2025, it had subsidiaries in about 50 countries worldwide and manufacturing operations in about 20 countries. Following a fourth-quarter 2025 segment realignment, it reports its financial results in two reportable segments: Healthcare & Water Technologies and Diversified Industrials. Its Healthcare & Water Technologies segment includes high-performance packaging and parts and components for medical device and biopharma markets, as well as water filtration and purification technologies for industrial wastewater and energy, municipal drinking water and desalination, and life sciences and specialty markets. Its Diversified Industrials segment includes building technologies serving new-build and repair/remodel applications across non-residential and residential construction markets, and industrial technologies comprising adhesive, wear and friction, and packaging solutions for aerospace, automotive and printing and packaging markets. At December 31, 2025, it owned about 6,100 patents and patent applications globally, of which about 4,700 were associated with its continuing operations. DuPont de Nemours, Inc. is a Delaware corporation formed in 2015, formerly named DowDuPont Inc., for the purpose of effecting the all-stock merger of equals between The Dow Chemical Company and E. I. du Pont de Nemours and Company, which became effective on August 31, 2017.

Written from the business description in DuPont de Nemours, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 17 February 2026. Every sentence was checked against that document before publication.

Growth

USD 6.8B

Revenue, FY2025 · full 11-year series below

Revenue $B Net income $B

FY2025 · Revenue 6.8 · Net income -0.8

Compound annual growth

Revenue

−19.3%

−9.3%

−17.8%

Dividend / share

+2.7%

+3.6%

Returned to shareholders

−2.9%

−10.8%

−16.0%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at −9.3% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−11 cents

lost on every revenue dollar

Operating margin Net margin

FY2025 · Operating 2.9% · Net -10.8%

ROE

FY2025 · ROE -4.2%

Gross margin34.5%

Operating margin2.9%

Net margin-10.8%

Return on assets-2.5%

EBITDAUSD 847.0M

Each USD of equity lost 4 cents this year.

Cash & shareholders

USD 597.0M

returned in FY2025 · dividends + net buybacks

Free cash flow $B

FY2025 · FCF 0.2

Net buybacks $B Dividends $B

FY2025 · Dividends 0.6 · Net buybacks —

Dividends paidUSD 597.0M

Net buybacks—

Share of profit-76.6%

Consecutive raises—

USD 597.0M in dividends went back to shareholders in a year without profit.

Total assetsUSD 21.6B

EquityUSD 13.9B

CashUSD 715.0M

Gross debtUSD 3.1B

Net debtUSD 2.4B

Current ratio2.42×

Net debt stands at 17% of equity.

The 11-year record

11 fiscal years

Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue $B	6.8	6.7	6.6	13.0	12.6	11.1	15.4	22.6	11.7	48.2	48.8
Operating income $B	0.2	0.1	−0.3	1.4	1.4	−1.3	−0.1	0.6	−1.5	4.4	9.9
EBITDA $B	0.8	0.8	0.3	2.6	2.6	1.8	3.1	2.8	−0.5	7.3	12.5
Income tax $B	0.1	0.2	−0.2	0.4	0.2	0.1	−0.0	0.2	−1.8	0.0	2.1
Net income $B	−0.8	0.7	0.4	5.9	6.5	−3.0	0.5	3.8	1.2	4.3	7.7
Free cash flow $B	0.2	0.5	0.5	0.6	1.1	2.9	−1.1	3.5	−1.3	−6.8	3.9
EPS, diluted $	−1.86	1.68	0.94	11.75	11.89	−4.01	0.67	4.96	2.15	3.52	6.15
Dividend / sh $	1.43	1.52	1.44	1.32	1.20	1.20	2.16	4.56	5.28	1.84	1.72
Payout %	−77	90	154	11	10	−30	323	91	293	57	29
ROE %	−4.2	3.0	1.7	22.1	19.9	−7.4	0.7	4.0	1.8	16.6	·
Shares out B	·	·	·	·	·	0.73	0.74	0.78	0.78	0.41	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 45 reconciliationsAUDITED

Reconciled in 11 of 19 fiscal years. 42 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityPlastic Materials, Synth Resins & Nonvulcan Elastomers

Listed onNYSE

Incorporated inDelaware

Fiscal year endsDecember 31

Data on record since2015